Skip to main content

Bayer CropScience’s profit declines in 2018-19

Bayer CropScience has registered revenue from operations of Rs. 26,85.7 crore, compared to Rs. 27,49 crore in the previous year

Related Category: Sub Category:

In the wake of weaker sales in Rabi season, Bayer CropScience’s profit has dipped in FY 2018-19. The company has announced its audited results for the financial year (FY) and quarter ending March 31, 2019. In FY 2018-19, the company registered revenue from operations of Rs. 26,85.7 crore, compared to Rs. 27,49 crore in the previous year. Profit for the year stood at Rs. 2,37.6 crore, compared to Rs. 3,00.1 crore in the previous year.
In Q4 of FY 2018-19, the company registered revenue from operations of Rs. 1,28.8 crore and loss for the quarter of Rs. 79.8 crore. Highlighting the quarterly results, D. Narain, Vice Chairman & Managing Director and CEO of Bayer CropScience said, “Adverse weather and drought led to a weaker than expected Rabi season. This affected our fourth quarter performance and we shifted our focus on receivables collection and channel inventory reduction. While overall crop economics remain stressed in the near-term, we are convinced about the long-term potential of the market. We will continue to contribute towards sustainable agriculture and prosperity for Indian farmers through product innovation, digitalisation and partnerships,” Narain added.
Sharing the future outlook for Bayer CropScience, Narain, said, “Based on the anticipated completion of the merger in India, we envisage new market opportunities and operational synergies from the integration with Monsanto. In the short to medium term, our robust line-up of new products in crop protection and hybrid seeds will help us expand our farmer reach to new crop segments.”

“We also plan new launches in Environmental Science to boost the Indian public health market. Besides new products, Bayer CropScience will accelerate business growth through new business models that will offer tailored agronomic solutions to farmers,” Narain added.
The Board of Directors have recommended a dividend payment of Rs. 18 per equity share of Rs.10 each for the financial year ended March 31, 2019, subject to the shareholders’ approval.
Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the group aims to increase its earning power and create value through innovation and growth.

Votes with an average with

Related Story

Hatsun Agro Product to expand to 3,500 retail outlets soon

Hatsun Agro Product, India's leading private sector dairy company will reach the retail milestone of 3,500 outlets by July 2019. Currently, the retail network of HAP includes 3,420 company direct…

India to host mega food processing event in November

World Food India 2019 will be held from 1-4th November 2019 in New Delhi and will position India as food processing destination of the world. It will be the biggest gathering of all global and…

Dairy Day launches Chilli Guava

Dairy Day, a leading ice cream brand in South India, has launched ‘Chilli Guava’, a delicious mix of guava fruit pulp, chilli and salt in Bengaluru today. Dairy Day’s Chilli Guava brings the…

The website encountered an unexpected error. Please try again later.